Long-Term Safety Database

Long-term safety database aggregates adverse event reports spanning years post-approval identifying rare events. Spontaneous reporting captures unexpected adverse effects. Periodic Safety Update Reports summarise cumulative safety. Signal detection algorithms identify emerging patterns. International collaboration pools limited patient populations.

Regulatory submissions incorporate database findings. Pharmacovigilance plans establish monitoring strategies. Event classification standardisation enables comparison. Quality assurance verifies data completeness. Post-approval actions address identified safety signals.